Novel PVA-based hydrogel microparticles for doxorubicin delivery.
about
Therapeutic angiogenesis: controlled delivery of angiogenic factors.Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery ApplicationsHybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.Methods for Generating Hydrogel Particles for Protein DeliveryConcentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles.Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles.PVA hydrogels containing beta-cyclodextrin for enhanced loading and sustained release of ocular therapeutics.Micro- and Nanoscale Hydrogel Systems for Drug Delivery and Tissue Engineering.Polymeric Microspheres for Medical Applications.Liposomal Templating, Association with Mammalian Cells, and Cytotoxicity of Poly(vinyl alcohol) Physical Hydrogel NanoparticlesModified biopolymer-dextrin based crosslinked hydrogels: application in controlled drug deliveryEngineering of nanometer-sized cross-linked hydrogels for biomedical applicationsDynamics of Nanostructures for Drug Delivery: the Potential of QENSPolymer and Water Dynamics in Poly(vinyl alcohol)/Poly(methacrylate) Networks. A Molecular Dynamics Simulation and Incoherent Neutron Scattering InvestigationPreparation of magnetic polyvinyl alcohol composite nanofibers with homogenously dispersed nanoparticles and high water resistanceEeonomer 200F®: A High-Performance Nanofiller for Polymer Reinforcement—Investigation of the Structure, Morphology and Dielectric Properties of Polyvinyl Alcohol/Eeonomer-200F® Nanocomposites for Embedded Capacitor Applications
P2860
Q27023731-45E90AF3-21C6-43BC-86CC-8F1C76C6E382Q28552162-F25EE5E6-008C-499C-8CC4-B90B88480B25Q36920492-54B08997-AA23-4ECE-B3E5-CF705B405055Q37790704-FABF120D-3687-47DF-996F-A9B0B3DF8E44Q38830066-B88ED3D2-6AD9-435A-A772-1FAC25BE96C8Q40497895-56F1D8EE-D2E6-4548-AAC8-2D9FF90CF522Q41064335-B2F4C433-783F-4D55-916B-D76CEC8D93C5Q43052449-CFD0C9A3-4C91-40E6-A693-6B6C9B7354A2Q45860907-5E39F0BA-A99E-461E-A577-C4391790ED84Q46716924-489BD736-C558-42B3-8A4D-12564DC996ECQ56769217-4E3E0C77-B6E8-46F9-9544-0962F381D8CAQ57348080-A069C39B-7B11-456F-876F-B00B743BE8DDQ57370446-EDCAF847-3CDD-4A58-80A6-199DF671A0C3Q57371642-95ED11A5-558E-4FF3-9337-1F2E37C1FCEFQ57373259-0329EC02-0237-4998-9EF3-2EBD05156BFAQ57380828-F7A37B61-F6A0-4DCD-A4A8-0606C618374AQ58309705-90118BFA-0CD2-4A61-B049-0978741AFFEE
P2860
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@ast
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@en
type
label
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@ast
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@en
prefLabel
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@ast
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@en
P2093
P50
P356
P1433
P1476
Novel PVA-based hydrogel microparticles for doxorubicin delivery.
@en
P2093
Lucia Viganò
Mark F Telling
Raffaella Villa
P304
P356
10.1021/BM800225V
P577
2008-06-06T00:00:00Z